Jennison Associates LLC Eli Lilly & CO Transaction History

Jennison Associates LLC

$149 Billion
Q1 2024

A detailed history of Jennison Associates LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Jennison Associates LLC holds 7,466,502 shares of LLY stock, worth $6.13 Billion. This represents 3.9% of its overall portfolio holdings.

Number of Shares

7,466,502

Previous 7,597,612 1.73%

Holding current value

$6.13 Billion

Previous $4.43 Billion 31.16%

% of portfolio

3.9%

Previous 3.33%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$592.2 - $792.28 $77.6 Million - $104 Million	-131,110 Reduced 1.73%	7,466,502 $5.81 Billion
Q4 2023 Feb 01, 2024	SELL	$525.19 - $619.13 $425 Million - $501 Million	-810,001 Reduced 9.63%	7,597,612 $4.43 Billion
Q3 2023 Oct 31, 2023	SELL	$434.7 - $599.3 $75.6 Million - $104 Million	-173,825 Reduced 2.03%	8,407,613 $4.52 Billion
Q2 2023 Aug 03, 2023	BUY	$350.74 - $468.98 $2.55 Million - $3.41 Million	7,274 Added 0.08%	8,581,438 $4.02 Billion
Q1 2023 Apr 26, 2023	SELL	$310.63 - $364.82 $576 Million - $677 Million	-1,854,917 Reduced 17.79%	8,574,164 $2.94 Billion

Q4 2022 Feb 09, 2023	BUY	$321.55 - $374.67 $117 Million - $137 Million	364,339 Added 3.62%	10,429,081 $3.82 Billion
Q3 2022 Nov 01, 2022	SELL	$296.48 - $337.87 $87 Million - $99.1 Million	-293,324 Reduced 2.83%	10,064,742 $3.25 Billion
Q2 2022 Aug 02, 2022	BUY	$278.73 - $327.27 $685 Million - $804 Million	2,456,760 Added 31.09%	10,358,066 $3.36 Billion
Q1 2022 May 11, 2022	SELL	$234.69 - $291.66 $294 Million - $366 Million	-1,254,308 Reduced 13.7%	7,901,306 $2.26 Billion
Q4 2021 Feb 08, 2022	SELL	$224.85 - $279.04 $159 Million - $198 Million	-708,902 Reduced 7.19%	9,155,614 $2.53 Billion
Q3 2021 Nov 09, 2021	BUY	$221.6 - $272.71 $211 Million - $260 Million	953,521 Added 10.7%	9,864,516 $2.28 Billion
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $627 Million - $811 Million	3,470,858 Added 63.8%	8,910,995 $2.05 Billion
Q1 2021 May 11, 2021	BUY	$164.32 - $212.72 $585 Million - $758 Million	3,561,294 Added 189.55%	5,440,137 $1.02 Billion
Q4 2020 Feb 05, 2021	SELL	$130.46 - $172.63 $352 Million - $466 Million	-2,701,830 Reduced 58.98%	1,878,843 $317 Million
Q3 2020 Nov 04, 2020	SELL	$146.22 - $169.13 $509 Million - $589 Million	-3,482,699 Reduced 43.19%	4,580,673 $678 Million
Q2 2020 Aug 06, 2020	SELL	$136.42 - $164.18 $290 Million - $349 Million	-2,128,680 Reduced 20.89%	8,063,372 $1.32 Billion
Q1 2020 May 06, 2020	BUY	$119.05 - $147.35 $676 Million - $837 Million	5,679,574 Added 125.86%	10,192,052 $1.41 Billion
Q4 2019 Feb 07, 2020	BUY	$106.92 - $132.43 $338 Million - $418 Million	3,157,292 Added 232.98%	4,512,478 $593 Million
Q3 2019 Nov 08, 2019	SELL	$106.79 - $116.16 $23.3 Million - $25.4 Million	-218,457 Reduced 13.88%	1,355,186 $152 Million
Q2 2019 Aug 06, 2019	SELL	$110.79 - $129.32 $230 Million - $269 Million	-2,077,373 Reduced 56.9%	1,573,643 $0
Q1 2019 May 10, 2019	BUY	$111.31 - $131.02 $25.1 Million - $29.6 Million	225,592 Added 6.59%	3,651,016 $474 Million
Q4 2018 Feb 06, 2019	BUY	$105.9 - $118.64 $136 Million - $152 Million	1,280,878 Added 59.73%	3,425,424 $396 Million
Q3 2018 Nov 08, 2018	BUY	$85.86 - $107.31 $20.8 Million - $26 Million	242,577 Added 12.75%	2,144,546 $230 Million
Q2 2018 Aug 02, 2018	BUY	$75.7 - $86.88 $626,190 - $718,671	8,272 Added 0.44%	1,901,969 $162 Million
Q1 2018 Apr 20, 2018	SELL	$74.21 - $87.6 $28.5 Million - $33.6 Million	-383,990 Reduced 16.86%	1,893,697 $147 Million
Q4 2017 Jan 25, 2018	BUY	$81.94 - $87.89 $22.2 Million - $23.8 Million	270,921 Added 13.5%	2,277,687 $192 Million
Q3 2017 Nov 03, 2017	BUY	$77.07 - $85.54 $155 Million - $172 Million	2,006,766	2,006,766 $172 Million

Others Institutions Holding LLY

# of Institutions

3,712

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $779B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Account

Jennison Associates LLC Eli Lilly & CO Transaction History